Variant report
Variant | nsv582533 |
---|---|
Chromosome Location | chr2:101086151-101103384 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:274)
- CpG islands (count:244)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:101087575-101087625 | BE2_C | brain: | n/a |
2 | chr2:101086756-101086806 | NT2-D1 | testis: | n/a |
3 | chr2:101086756-101086806 | SK-N-MC | brain: | n/a |
4 | chr2:101086893-101086943 | GM12891 | blood: | n/a |
5 | chr2:101086756-101086806 | BJ | skin: | n/a |
6 | chr2:101086893-101086943 | SK-N-MC | brain: | n/a |
7 | chr2:101086756-101086806 | GM12878 | blood: | n/a |
8 | chr2:101087575-101087625 | HRCEpiC | kidney: | n/a |
9 | chr2:101086893-101086943 | H1-hESC | embryonic stem cell: | embryo |
10 | chr2:101087575-101087625 | PANC-1 | pancreas: | n/a |
11 | chr2:101086893-101086943 | SK-N-SH | brain: | n/a |
12 | chr2:101087575-101087625 | AG04450 | lung: | fetal |
13 | chr2:101086756-101086806 | H1-hESC | embryonic stem cell: | embryo |
14 | chr2:101086963-101087013 | AG09319 | gingival: | n/a |
15 | chr2:101086963-101087013 | HMEC | breast: | n/a |
16 | chr2:101086756-101086806 | SAEC | small airway: | n/a |
17 | chr2:101086963-101087013 | HRPEpiC | eye: | n/a |
18 | chr2:101086963-101087013 | NHBE | bronchial: | n/a |
19 | chr2:101086893-101086943 | AG10803 | skin: | n/a |
20 | chr2:101086963-101087013 | PrEC | prostate: | n/a |
21 | chr2:101086756-101086806 | Jurkat | blood: | n/a |
22 | chr2:101086756-101086806 | SK-N-SH_RA | brain: | n/a |
23 | chr2:101086756-101086806 | HIPEpiC | eye: | n/a |
24 | chr2:101086963-101087013 | HCM | heart: | n/a |
25 | chr2:101086893-101086943 | ECC-1 | luminal epithelium: | n/a |
26 | chr2:101086893-101086943 | GM06990 | blood: | n/a |
27 | chr2:101086963-101087013 | AoSMC | blood vessel: | n/a |
28 | chr2:101086893-101086943 | HRPEpiC | eye: | n/a |
29 | chr2:101086756-101086806 | HepG2 | liver: | n/a |
30 | chr2:101086756-101086806 | AG04450 | lung: | fetal |
31 | chr2:101086963-101087013 | SAEC | small airway: | n/a |
32 | chr2:101086963-101087013 | HNPCEpiC | eye: | n/a |
33 | chr2:101086893-101086943 | HRE | kidney: | n/a |
34 | chr2:101086893-101086943 | Jurkat | blood: | n/a |
35 | chr2:101086963-101087013 | AG04449 | skin: | fetal |
36 | chr2:101086756-101086806 | HCF | heart: | n/a |
37 | chr2:101086756-101086806 | GM06990 | blood: | n/a |
38 | chr2:101086893-101086943 | BJ | skin: | n/a |
39 | chr2:101087575-101087625 | NHBE | bronchial: | n/a |
40 | chr2:101086756-101086806 | HCM | heart: | n/a |
41 | chr2:101086963-101087013 | Hepatocyte | liver: | n/a |
42 | chr2:101086893-101086943 | PANC-1 | pancreas: | n/a |
43 | chr2:101087575-101087625 | AoSMC | blood vessel: | n/a |
44 | chr2:101086963-101087013 | HRE | kidney: | n/a |
45 | chr2:101087575-101087625 | CMK | blood: | n/a |
46 | chr2:101086893-101086943 | GM12878 | blood: | n/a |
47 | chr2:101086756-101086806 | ECC-1 | luminal epithelium: | n/a |
48 | chr2:101087575-101087625 | NT2-D1 | testis: | n/a |
49 | chr2:101086756-101086806 | SK-N-SH | brain: | n/a |
50 | chr2:101086893-101086943 | HIPEpiC | eye: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:101100078..101102240-chr2:101176769..101179380,2 | K562 | blood: | |
2 | chr2:101087589..101089414-chr2:101093302..101095563,2 | K562 | blood: | |
3 | chr2:101087589..101089414-chr2:101093302..101095563,2 | K562 | blood: | |
4 | chr2:101101769..101103821-chr2:101257032..101259375,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NMS | TF binding region |
NMS | CpG island |
ENSG00000115539 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10166865 | chr2:101086151-101086152 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186545935 | chr2:101086180-101086181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190943430 | chr2:101086201-101086202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556515436 | chr2:101086209-101086210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150305331 | chr2:101086214-101086215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182888109 | chr2:101086257-101086258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537779516 | chr2:101086290-101086291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562163171 | chr2:101086318-101086319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572575268 | chr2:101086320-101086321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540731807 | chr2:101086362-101086363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556114059 | chr2:101086368-101086369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563799116 | chr2:101086370-101086371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532855016 | chr2:101086391-101086392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574396584 | chr2:101086396-101086397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10203739 | chr2:101086422-101086423 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs376243148 | chr2:101086427-101086428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186616416 | chr2:101086454-101086455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537097168 | chr2:101086483-101086484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572184074 | chr2:101086484-101086485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149541166 | chr2:101086488-101086489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144114814 | chr2:101086538-101086539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59335919 | chr2:101086553-101086554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532841598 | chr2:101086577-101086578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551032795 | chr2:101086652-101086653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529189164 | chr2:101086702-101086703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549231367 | chr2:101086771-101086772 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs6755846 | chr2:101086799-101086800 | Enhancers | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs375595217 | chr2:101086802-101086803 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs138830523 | chr2:101086803-101086804 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs529999344 | chr2:101086837-101086838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548574163 | chr2:101086856-101086857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551591146 | chr2:101086873-101086874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs13385681 | chr2:101086894-101086895 | Enhancers | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs142782392 | chr2:101086898-101086899 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs112797837 | chr2:101086913-101086914 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs369594294 | chr2:101086920-101086921 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs373653693 | chr2:101086925-101086926 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs191121983 | chr2:101086941-101086942 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs59029020 | chr2:101086951-101086952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs76201870 | chr2:101086952-101086953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183314287 | chr2:101086964-101086965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13411940 | chr2:101086966-101086967 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs368599926 | chr2:101087077-101087078 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564338121 | chr2:101087078-101087079 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577352628 | chr2:101087082-101087083 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142859719 | chr2:101087102-101087103 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13414632 | chr2:101087104-101087105 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs528834233 | chr2:101087128-101087129 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150623769 | chr2:101087134-101087135 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559637073 | chr2:101087161-101087162 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21509527 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:101085400-101086600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr2:101086600-101087000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr2:101086800-101087000 | Enhancers | Spleen | Spleen |
4 | chr2:101087000-101087200 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr2:101087200-101087400 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
6 | chr2:101087200-101087400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr2:101095400-101095600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr2:101095600-101104200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |